Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Nay

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Bulletin Du Cancer|February 9, 2023
[Immunotherapy in oncogynaecology]Paula Nay, Philippe Morice, Felix Blanc-Durand
Cancer Medicine|October 20, 2022
The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapyRita Bentahila, Philippe Giraud, Pierre Decazes, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
Frontiers in Oncology|April 1, 2022
Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective StudyHenri Plais, Marie Labruyère, Thibault Creutin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Bulletin Du Cancer|February 9, 2023
[Immunotherapy in oncogynaecology]Paula Nay, Philippe Morice, Felix Blanc-Durand
Cancer Medicine|October 20, 2022
The impact of sarcopenia on survival and treatment tolerance in patients with head and neck cancer treated with chemoradiotherapyRita Bentahila, Philippe Giraud, Pierre Decazes, et al.
Journal for Immunotherapy of Cancer|May 19, 2025
Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL studyLeonard Depotte, Paula Nay, Christophe Borg, et al.
Frontiers in Oncology|April 1, 2022
Outcomes of Patients With Active Cancer and COVID-19 in the Intensive-Care Unit: A Multicenter Ambispective StudyHenri Plais, Marie Labruyère, Thibault Creutin, et al.
European Journal of Cancer (Oxford, England : 1990)|April 4, 2025
Activity of lenvatinib-based therapy in previously treated patients with metastatic renal cell carcinoma: A European multicenter study (LENVA-LAT)Javier Gavira, Edouard Auclin, Macarena Rey-Cardenas, et al.
Pageof 1